QINGHAI SPRING MEDICINAL RESOURCES TECHNOLOGY CO., LTD. Qinghai Spring Medicinal Resources Technology Co., Ltd. Stock
Equities
600381
CNE0000017W0
Pharmaceuticals
|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 3.34 CNY | -5.11% |
|
-22.51% | -56.79% |
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Last Days!
Take advantage of the offer
* See conditions on site
| Sales 2022 | 160M 22.15M | Sales 2023 | 214M 29.57M | Capitalization | 4.54B 627M |
|---|---|---|---|---|---|
| Net income 2022 | -288M -39.82M | Net income 2023 | -268M -37.06M | EV / Sales 2022 | 44.1 x |
| Net cash position 2022 | 164M 22.74M | Net cash position 2023 | 154M 21.33M | EV / Sales 2023 | 20.5 x |
| P/E ratio 2022 |
-25.1
x | P/E ratio 2023 |
-16.8
x | Employees | 175 |
| Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 55.91% |
More Fundamentals
* Assessed data
More news
More press releases
| 1 day | -5.11% | ||
| 1 week | -22.51% | ||
| Current month | -26.43% | ||
| 1 month | -30.13% | ||
| 3 months | -33.47% | ||
| 6 months | -57.99% | ||
| Current year | -56.79% |
1 week
3.34
3.89
1 month
3.344.67
Current year
3.348.28
1 year
3.3410.09
3 years
3.3420.67
5 years
3.3420.67
10 years
3.3450.09
| Managers | Title | Age | Since |
|---|---|---|---|
Xue Feng Zhang
CEO | Chief Executive Officer | 55 | 15-10-29 |
Lin Wang
DFI | Director of Finance/CFO | 55 | 18-05-17 |
Tie Peng Yao
BRD | Director/Board Member | 71 | 15-05-14 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Xue Min Gao
BRD | Director/Board Member | 86 | 20-06-03 |
Rong Xiao
BRD | Director/Board Member | 54 | - |
Xue Feng Zhang
CEO | Chief Executive Officer | 55 | 15-10-29 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 0.00% | 34 M€ | +3.39% | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-05-13 | 3.34 | -5.11% | 761,800 |
| 24-05-10 | 3.52 | -4.86% | 940,200 |
| 24-05-09 | 3.7 | -4.88% | 959,100 |
| 24-05-08 | 3.89 | -4.89% | 754,200 |
| 24-05-07 | 4.09 | -5.10% | 504,400 |
End-of-day quote Shanghai S.E., May 12, 2024
More quotes
QINGHAI SPRING MEDICINAL RESOURCES TECHNOLOGY CO.,LTD is a China-based company that principally engaged in the integrated development, utilization, production, sales and consulting services of the natural advantageous resources on the Qinghai-Tibet plateau, as well as the development and utilization of other biological resources. The Companyâs main products are the cordyceps sinensis series products under Verygrass brand, which includes cordyceps sinensis pure powder tablet, processed cordyceps sinensis and raw cordyceps sinensis. The Companyâs subsidiary is Qinghai Spring Pharmaceutical Resource Utilization Co Ltd.
Sector
Pharmaceuticals
Calendar
2024-08-26
- Q2 2024 Earnings Release (Projected)
Annual profits - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -56.79% | 286M | |
| +43.17% | 6.16B | |
| -14.69% | 4.46B | |
| -8.17% | 3.27B | |
| +6.95% | 3.2B | |
| -1.76% | 2.6B | |
| +50.20% | 1.98B | |
| -7.85% | 1.7B | |
| -0.40% | 1.66B | |
| -9.91% | 1.61B |
- Stock Market
- Equities
- 600381 Stock